By Kenneth Bonett
For the last five years, I’ve kept coming back to the same question: is intermittent fasting actually doing something unique, or is it just making people eat less?
A recent review examined how intermittent fasting may influence immune aging, a process scientists call immunosenescence. The paper lays out a compelling case. IF may exert immunoregulatory effects through metabolic remodeling, cellular stress responses, and inflammatory signaling. In both preclinical and human studies, IF appears to attenuate pro-inflammatory cytokine production, enhance autophagy, and improve immune cell function.
The proposed mechanisms are real. Fasting triggers a rise in beta-hydroxybutyrate (BHB), which suppresses NLRP3 inflammasome activation and lowers pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α. It modulates gut microbiota toward short-chain fatty acid-producing taxa. It improves insulin sensitivity. It reduces ceramides and oxidative stress. At the level of the brain, these pathways converge on improved cognitive function, increased neuroplasticity, and reduced neuroinflammation.
On the surface, this sounds compelling.
But these effects aren’t unique to intermittent fasting.
When calorie intake is held constant, many of these benefits look very similar to simple caloric restriction. In healthy humans undergoing moderate caloric restriction of roughly 14% over two years, there was evidence of increased thymic output, reduced fat infiltration in the thymus, and transcriptional changes consistent with improved mitochondrial bioenergetics and reduced inflammation. The same core pathways keep appearing regardless of approach: downregulation of mTOR, activation of AMPK, improved insulin sensitivity, and upregulation of autophagy.
So the real question isn’t whether fasting works. It’s whether fasting is uniquely beneficial, or just a different path to the same outcome.
From what we know so far, many of the benefits appear to overlap. Whether intermittent nutritional modulation can achieve a “sweet spot” sufficient to maintain immune vigilance while promoting longevity-associated phenotypes remains to be determined in well-designed clinical trials.
That doesn’t make fasting useless. It makes it a tool.
There may be additional effects beyond calories alone, including circadian alignment, metabolic flexibility, and adherence differences, but those are still being worked out. There is a plausible mechanism in the cyclic metabolic switch, where the repeated transition between fed and fasting states could enhance long-term cellular resilience to stress. But plausible and proven are different things.
If you use fasting, the fundamentals still apply: hit your daily protein intake and control total calories. I’ve used a 16:8 approach before (16-hour fasting window, 8-hour eating window).
For longevity, fasting is a tool. It’s likely not the only path to the same benefits.
NOT MEDICAL ADVICE.
Reference: Alkawamleh D, Madkour MI, Kalam F, Abdelrahim DN, Abdallah HW and Faris ME (2026). Intermittent fasting and immune aging: implications for immunosenescence, inflammaging, neuroinflammation, and frailty. Front. Nutr. 13:1736969. doi: 10.3389/fnut.2026.1736969
